Sanofi drops option, inks $750M R&D collaboration with Warp Drive Bio

John Carroll

Three years after signed on to back Cambridge, MA-based Bio, taking an to buy, the pharma giant has stepped back up to retool the terms, opting for a 5-year potentially worth $ 750 million while leaving the biotech free to pursue its own independent future.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS